Physician profile
Thomas C Curtis
NPI 1932282043
$437.64
in general payments reported to CMS, 2019-2025
10 companies · $88.35 in 2025
The $88.35 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.02 · 2021: $11.04 · 2022: $70.45 · 2023: $138 · 2024: $114 · 2025: $88.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $150.52 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $86.87 | 2022-2025 | Mounjaro, Zepbound |
| Irhythm Technologies, INC. | $52.65 | 2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $49.82 | 2022-2023 | |
| Ethicon US, LLC | $23.03 | 2022 | |
| Baxter Healthcare | $17.83 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $16.02 | 2020 | |
| Merck Sharp & Dohme LLC | $15.80 | 2025 | Gardasil 9, Capvaxive |
| Glaxosmithkline, LLC. | $14.06 | 2023 | Shingrix, Arexvy |
| Amgen INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.